The Neurobiology of Aging and Alzheimer Disease in Down Syndrome
Editat de Elizabeth Head, Ira Lotten Limba Engleză Paperback – 27 aug 2021
- Discusses the complexities involved with aging and Alzheimer’s disease in Down syndrome
- Summarizes the neurobiology of aging that requires management in adults with DS and leads to healthier aging and better quality of life into old age
- Serves as learning tool to orient researchers to the key challenges and offers insights to help establish critical areas of need for further research
Preț: 720.54 lei
Preț vechi: 879.31 lei
-18% Nou
Puncte Express: 1081
Preț estimativ în valută:
137.89€ • 143.09$ • 115.25£
137.89€ • 143.09$ • 115.25£
Carte tipărită la comandă
Livrare economică 10-24 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128188453
ISBN-10: 0128188456
Pagini: 352
Ilustrații: 80 illustrations (30 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0128188456
Pagini: 352
Ilustrații: 80 illustrations (30 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Public țintă
Researchers, investigators, PhD students and postdocs as well as clinicians in the fields of aging, Down syndrome and Alzheimer’s diseaseCuprins
1. Introduction
2. Alzheimer’s neuropathology in Down syndrome: From gestation to old age
3. The contribution of inflammation to Alzheimer’s disease in Down syndrome
4. The role of cerebrovascular disease in aging and Alzheimer’s disease among people with Down syndrome
5. Oxidative stress and mTOR in Down syndrome brain: Link to Alzheimer’s dysmetabolism, neuropathology, and possible therapies
6. Fluid biomarkers for Alzheimer’s disease in Down syndrome: Current status and novel trends
7. Proteomic and metabolomic biomarkers of Alzheimer’s disease: Opportunities to advance precision medicine and clinical trials
8. Magnetic resonance imaging biomarkers for cognitive decline in Down syndrome
9. PET imaging in Down syndrome and Alzheimer’s disease
10. Genetics of Alzheimer’s disease in adults with Down syndrome
11. Co-occurring medical conditions in aging adults with Down syndrome
12. Sleep in aging adults with Down syndrome and its association with Alzheimer’s disease
13. Contributions of the neurological examination to the diagnosis of dementia in Down syndrome
14. Psychiatric issues in aging and dementia
15. Cognitive profile of aging and dementia
16. Clinical trials for Alzheimer’s disease in Down syndrome
17. Future directions
Index
2. Alzheimer’s neuropathology in Down syndrome: From gestation to old age
3. The contribution of inflammation to Alzheimer’s disease in Down syndrome
4. The role of cerebrovascular disease in aging and Alzheimer’s disease among people with Down syndrome
5. Oxidative stress and mTOR in Down syndrome brain: Link to Alzheimer’s dysmetabolism, neuropathology, and possible therapies
6. Fluid biomarkers for Alzheimer’s disease in Down syndrome: Current status and novel trends
7. Proteomic and metabolomic biomarkers of Alzheimer’s disease: Opportunities to advance precision medicine and clinical trials
8. Magnetic resonance imaging biomarkers for cognitive decline in Down syndrome
9. PET imaging in Down syndrome and Alzheimer’s disease
10. Genetics of Alzheimer’s disease in adults with Down syndrome
11. Co-occurring medical conditions in aging adults with Down syndrome
12. Sleep in aging adults with Down syndrome and its association with Alzheimer’s disease
13. Contributions of the neurological examination to the diagnosis of dementia in Down syndrome
14. Psychiatric issues in aging and dementia
15. Cognitive profile of aging and dementia
16. Clinical trials for Alzheimer’s disease in Down syndrome
17. Future directions
Index